Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.  Journal of Interferon and Cytokine Research.  42:301-315. 2022
2021 Pathogenesis of iga nephropathy: Current understanding and implications for development of disease-specific treatment.  Journal of Clinical Medicine.  10. 2021
2021 Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.  Journal of Autoimmunity.  118. 2021
2021 Immunoglobulin A Glycosylation and Its Role in Disease 2021
2020 Assigning immunoglobulin class from single-cell transcriptomes in IgA1-secreting versus membrane subpopulations.  BioTechniques: the journal of laboratory technology for bioresearch.  70:89-99. 2020
2019 Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression (PLoS One (2019) 14:2 (e0212254) DOI: 10.1371/journal.pone.0212254).  PLoS One.  14. 2019
2019 Glycosylation in health and disease.  Nature Reviews Nephrology.  15:346-366. 2019
2019 Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.  PLoS One.  14. 2019
2018 Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients.  BioTechniques: the journal of laboratory technology for bioresearch.  65:71-77. 2018
2017 GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.  PLoS Genetics.  13. 2017
2017 Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.  Kidney International Reports.  2:1194-1207. 2017
2016 Markers for the progression of IgA nephropathy.  Journal of Nephrology.  29:535-541. 2016
2016 The origin and activities of IgA1-containing immune complexes in IGA nephropathy.  Frontiers in Immunology.  7. 2016
2016 Somatic mutations modulate autoantibodies against galactose-deficient IgA1 in IgA nephropathy.  Journal of the American Society of Nephrology.  27:3278-3284. 2016
2016 Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.  Disease Markers.  2016. 2016
2015 New Insights into the Pathogenesis of IgA Nephropathy..  Kidney Diseases.  1:8-18. 2015
2014 Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease.  Journal of Immunology Research.  2014. 2014
2013 Mitochondrially targeted compounds and their impact on cellular bioenergetics.  Redox Biology.  1:86-93. 2013
2011 Assessing bioenergetic function in response to oxidative stress by metabolic profiling.  Free Radical Biology and Medicine.  51:1621-1635. 2011
2010 Prevention of diabetic nephropathy in Ins2+/-AkitaJ mice by the mitochondria-targeted therapy MitoQ.  Biochemical Journal.  432:9-19. 2010
2009 Methods for the determination and quantification of the reactive thiol proteome.  Free Radical Biology and Medicine.  47:675-683. 2009

Chapter

Year Title Altmetric
2016 Heterogeneity of aberrant O-glycosylation of IgA1 in IgA nephropathy.  53-68. 2016

Principal Investigator On

Investigator On

Education And Training

  • Doctor of Philosophy in Pathology/Human and Animal, University of Alabama at Birmingham 2012
  • Bachelor of Science or Mathematics in Biology, Saint Olaf College 2006

    • Full Name

  • Colin Reily